Syntal Capital Partners’s HCA Healthcare HCA Stock Holding History

Syntal Capital Partners’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,749	Closed	-$2.37M	–	91
2021 Q3	$2.37M	Buy	+9,749	New	+$2.38M	0.82%	25

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Syntal Capital Partners's HCA Position: Q4 2021 in Review

Syntal Capital Partners sold out of HCA Healthcare (HCA) in Q4 2021, closing a stake of 9,749 shares — an estimated $2.37M sold.

Syntal Capital Partners first reported a position in HCA in Q3 2021 and held it in 1 quarter. The position peaked at $2.37M in Q3 2021. 947 funds tracked by Wall St. Rank hold HCA as of Q4 2021.

Syntal Capital Partners reported no remaining HCA Healthcare position as of Q4 2021 after selling out during the quarter.
Syntal Capital Partners sold 9,749 HCA Healthcare shares in Q4 2021, an estimated $2.37M.
Syntal Capital Partners first reported a position in HCA Healthcare in Q3 2021 and held it in 1 quarter.
Syntal Capital Partners's HCA Healthcare position peaked at $2.37M in Q3 2021.
947 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2021.

Based on Syntal Capital Partners's 13F filing for Q4 2021, filed 11 Feb 2022.